| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.0024 |
1 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
| mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.001 |
1 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
| mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.001 |
1 |